Runner World interpretation: Running has been studied as a therapeutic activity for mental health across several clinical and experimental investigations. Randomized trials have shown that structured running programs can achieve remission rates comparable to antidepressant medication in adults with depression or anxiety, while also delivering physical health benefits. Acute bouts of running elevate circulating endocannabinoids, compounds linked to mood regulation. Observational studies further suggest that participation in running during adolescence is associated with increased adulthood physical activity, providing a foundation for lifelong health habits. Evidence basis: PMID 36828150, PMID 34870469, PMID 38965532
This guide is general educational information, not a diagnosis, treatment plan or individualized exercise prescription. Recent surgery, pregnancy, chronic illness, medication concerns, significant symptoms and return from injury require advice from an appropriately qualified clinician.
Clinical trial evidence in depressive and anxiety disorders
Peer-reviewed finding: A partially randomized patient‑preference trial assigned 141 adults with depression or anxiety to either 16 weeks of group‑based running therapy (minimum two sessions per week) or standard antidepressant medication (escitalopram or sertraline). At the end of treatment, remission was observed in 43.3 % of the running group and 44.8 % of the medication group, a non‑significant difference (p = .881). Evidence basis: PMID 36828150
Runner World interpretation: These comparable remission rates suggest that structured running may be a viable non‑pharmacological alternative for depressive or anxiety symptoms, especially when additional physical‑health benefits are desired. However, the trial involved supervised group sessions and participants who expressed a preference for exercise, which may limit applicability to unsupervised or less motivated individuals. Evidence basis: PMID 36828150
Acute exercise and endocannabinoid response
Peer-reviewed finding: A systematic review and meta‑analysis of 33 studies examined the acute impact of exercise on circulating endocannabinoids. The analysis found that anandamide (AEA) increased in 74 % of measured samples and that both AEA and 2‑arachidonoylglycerol (2‑AG) showed significant elevations immediately after exercise, regardless of modality, species, or health status. Evidence basis: PMID 34870469
Runner World interpretation: Because endocannabinoids are involved in stress regulation and mood, the observed acute rise may underlie short‑term affective improvements after running. Nevertheless, the studies varied widely in intensity, timing, and participant characteristics, and the review reported limited evidence for sustained changes with chronic exercise, indicating that longer‑term mental‑health effects remain uncertain. Evidence basis: PMID 34870469
Exercise‑induced stress resistance mechanisms
Peer-reviewed finding: A narrative review of animal research reported that voluntary wheel running prior to exposure to stressors reduces the emergence of depressive‑like, anxiety‑like, and post‑traumatic stress behaviours. These protective effects were observed across both sexes and across a range of stressor intensities, suggesting that prior physical activity can confer a robust stress‑resistance phenotype. Evidence basis: PMID 39080242
Runner World interpretation: While these animal findings provide mechanistic insight, translating them to human runners requires caution. Human stress responses are influenced by individual factors such as sex, exercise intensity, and type of stressor, and controlled trials are needed to determine whether comparable protective effects occur in people who engage in regular running. Evidence basis: PMID 39080242
Running interventions in chronic low back pain
Peer-reviewed finding: In a 12‑week randomized controlled trial, adults with chronic low back pain were assigned to a progressive run‑walk interval program or to a wait‑list control. Participants in the running group showed a statistically significant reduction in overall mental‑health scores measured by the Depression, Anxiety, and Stress Scale compared with controls (p = 0.012). Evidence basis: PMID 40820034
Peer-reviewed finding: The same cohort was examined for changes in systemic inflammatory markers (C‑reactive protein, interleukin‑8, and tumour necrosis factor‑α). Over the 12‑week period, no significant differences were observed between the running and control groups for any of these biomarkers, indicating that the mental‑health benefits occurred without measurable reductions in peripheral inflammation. Evidence basis: PMID 41785570
Practical considerations for running to support mental health
Peer-reviewed finding: The run‑walk intervention described in the low back pain trial was delivered digitally and supervised remotely. Participants performed three weekly sessions of 30 minutes each, progressing from walking to alternating intervals of running and walking, with intensity adjusted based on individual tolerance. Evidence basis: PMID 40820034
Runner World interpretation: Although the study demonstrated mental‑health improvements, it was conducted in a supervised setting and did not evaluate safety for unsupervised running. Consequently, it may be reasonable for individuals to reflect on their current health status and consider professional input when initiating a new running routine, while recognizing that the evidence does not prescribe specific safety protocols. Evidence basis: PMID 40820034, PMID 36828150